5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial

Documenti analoghi

• Increasing incidence of Barrett’s oesophagus in the general population
  di: van Soest, E M, et al.
  Pubblicazione: (2005)
• The homeodomain protein CDX2 is an early marker of Barrett’s oesophagus
  di: Moons, L M G, et al.
  Pubblicazione: (2004)
• Argon plasma coagulation therapy for ablation of Barrett’s oesophagus
  di: Deviere, J
  Pubblicazione: (2002)
• Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett’s oesophagus: factors determining persistence and recurrence of Barrett’s epithelium
  di: Basu, K K, et al.
  Pubblicazione: (2002)
• MUC4 is increased in high grade intraepithelial neoplasia in Barrett’s oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio
  di: Bax, D A, et al.
  Pubblicazione: (2004)